GRAL
GRAIL, Inc.NasdaqResearch view
Healthcare · Services-Medical Laboratories · Mid-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$3.6B
Enterprise Value$3.4B
Income$-408.4M
Sales$147.2M
Book/sh$57.71
Cash/sh$5.75
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio—
Current Ratio11.97
Debt/Eq—
EPS (ttm)$-11.11
EPS this Y82.5%
EPS past 3/5Y—
Sales past 3/5Y38.4%
EPS Y/Y TTM82.5%
Sales Y/Y TTM17.2%
Shs Outstand44.67M
ROA-14.0%
ROE-15.8%
ROIC-18.5%
Gross Margin—
Oper. Margin-382.0%
Profit Margin-277.5%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$55.5M
2023
$93.1M
2023
$125.6M
2024
$147.2M
2025
Financials — annual
SEC EDGAR · last 4 FY · tap a row to explain it| USD | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $55.5M | $93.1M | $125.6M | $147.2M |
| Gross Profit | — | — | — | — |
| Operating Income | $-5.4B | $-1.5B | $-2.2B | $-562.2M |
| Net Income | $-5.4B | $-1.5B | $-2.0B | $-408.4M |
| Diluted EPS | $-173.89 | $-47.21 | $-63.54 | $-11.11 |
| Operating Cash Flow | $-561.3M | $-595.8M | $-577.2M | $-299.0M |
| Free Cash Flow | $-584.2M | $-608.7M | $-582.4M | $-299.9M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Cash-flow detail unavailable in this filing.
—
COMMUNITY · $GRAL0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Services-Medical Laboratories
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.